Fairlie DP - Search Results

1

Nielsen DS, Shepherd NE, Xu W, Lucke AJ, Stoermer MJ, Fairlie DP. Nielsen DS, et al. Among authors: fairlie dp. Chem Rev. 2017 Jun 28;117(12):8094-8128. doi: 10.1021/acs.chemrev.6b00838. Epub 2017 May 25. Chem Rev. 2017. PMID: 28541045 Review.

2

Flavones are inhibitors of HIV-1 proteinase.

Brinkworth RI, Stoermer MJ, Fairlie DP. Brinkworth RI, et al. Among authors: fairlie dp. Biochem Biophys Res Commun. 1992 Oct 30;188(2):631-7. doi: 10.1016/0006-291x(92)91103-w. Biochem Biophys Res Commun. 1992. PMID: 1445308

3

Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors.

Leung D, Schroder K, White H, Fang NX, Stoermer MJ, Abbenante G, Martin JL, Young PR, Fairlie DP. Leung D, et al. Among authors: fairlie dp. J Biol Chem. 2001 Dec 7;276(49):45762-71. doi: 10.1074/jbc.M107360200. Epub 2001 Oct 1. J Biol Chem. 2001. PMID: 11581268 Free article.

4

Regioselective synthesis of antiparallel loops on a macrocyclic scaffold constrained by oxazoles and thiazoles.

Singh Y, Stoermer MJ, Lucke AJ, Glenn MP, Fairlie DP. Singh Y, et al. Among authors: fairlie dp. Org Lett. 2002 Oct 3;4(20):3367-70. doi: 10.1021/ol026463m. Org Lett. 2002. PMID: 12323020

5

Conformationally homogeneous cyclic tetrapeptides: useful new three-dimensional scaffolds.

Glenn MP, Kelso MJ, Tyndall JD, Fairlie DP. Glenn MP, et al. Among authors: fairlie dp. J Am Chem Soc. 2003 Jan 22;125(3):640-1. doi: 10.1021/ja029205t. J Am Chem Soc. 2003. PMID: 12526657

6

Designing supramolecular structures from models of cyclic peptide scaffolds with heterocyclic constraints.

Lucke AJ, Tyndall JD, Singh Y, Fairlie DP. Lucke AJ, et al. Among authors: fairlie dp. J Mol Graph Model. 2003 Mar;21(5):341-55. doi: 10.1016/s1093-3263(02)00181-x. J Mol Graph Model. 2003. PMID: 12543133

7

Cycloadditions of isobenzofuran to a constrained template bearing neighboring dienophiles.

Stoermer MJ, Butler DN, Warrener RN, Weerasuria KD, Fairlie DP. Stoermer MJ, et al. Among authors: fairlie dp. Chemistry. 2003 May 9;9(9):2068-71. doi: 10.1002/chem.200204619. Chemistry. 2003. PMID: 12740855

8

Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activity.

March DR, Proctor LM, Stoermer MJ, Sbaglia R, Abbenante G, Reid RC, Woodruff TM, Wadi K, Paczkowski N, Tyndall JD, Taylor SM, Fairlie DP. March DR, et al. Among authors: fairlie dp. Mol Pharmacol. 2004 Apr;65(4):868-79. doi: 10.1124/mol.65.4.868. Mol Pharmacol. 2004. PMID: 15044616

9

Alpha-turn mimetics: short peptide alpha-helices composed of cyclic metallopentapeptide modules.

Kelso MJ, Beyer RL, Hoang HN, Lakdawala AS, Snyder JP, Oliver WV, Robertson TA, Appleton TG, Fairlie DP. Kelso MJ, et al. Among authors: fairlie dp. J Am Chem Soc. 2004 Apr 21;126(15):4828-42. doi: 10.1021/ja037980i. J Am Chem Soc. 2004. PMID: 15080687

10

Enzymatic characterization and homology model of a catalytically active recombinant West Nile virus NS3 protease.

Nall TA, Chappell KJ, Stoermer MJ, Fang NX, Tyndall JD, Young PR, Fairlie DP. Nall TA, et al. Among authors: fairlie dp. J Biol Chem. 2004 Nov 19;279(47):48535-42. doi: 10.1074/jbc.M406810200. Epub 2004 Aug 18. J Biol Chem. 2004. PMID: 15322074 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

394 results

Search Page